Update of primary Helicobacter pylori resistance to antimicrobials in Brussels, Belgium.

Authors :: Miendje Deyi VY
Lare MS
Burette A
Ntounda R
Elkilic O
Cadranel S
Bontems P
Hallin M
Source :: Diagnostic microbiology and infectious disease [Diagn Microbiol Infect Dis] 2019 Dec; Vol. 95 (4), pp. 114875. Date of Electronic Publication: 2019 Jul 30.
Publication Year :: 2019
Abstract: This study aimed to follow the trend of primary antimicrobial resistance in Helicobacter pylori isolates obtained from several centers in Brussels. We observed increasing rates of primary resistance to macrolides (10.5% to 18%) to nitro-imidazoles (28% to 40%) and to fluoroquinolones (12.4% to 22.8%), respectively, from 2008/2009 to 2016.<br /> (Copyright © 2019 Elsevier Inc. All rights reserved.)

Subjects :: Belgium epidemiology
Gastric Mucosa microbiology
Helicobacter Infections epidemiology
Helicobacter pylori isolation & purification
Humans
Microbial Sensitivity Tests
Anti-Bacterial Agents pharmacology
Drug Resistance, Bacterial
Helicobacter Infections microbiology
Helicobacter pylori drug effects

Full Text Access

Tools